These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

707 related articles for article (PubMed ID: 29282133)

  • 1. Is amyotrophic lateral sclerosis/frontotemporal dementia an autophagy disease?
    Deng Z; Sheehan P; Chen S; Yue Z
    Mol Neurodegener; 2017 Dec; 12(1):90. PubMed ID: 29282133
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Common Molecular Pathways in Amyotrophic Lateral Sclerosis and Frontotemporal Dementia.
    Weishaupt JH; Hyman T; Dikic I
    Trends Mol Med; 2016 Sep; 22(9):769-783. PubMed ID: 27498188
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The emerging roles of microRNAs in the pathogenesis of frontotemporal dementia-amyotrophic lateral sclerosis (FTD-ALS) spectrum disorders.
    Gascon E; Gao FB
    J Neurogenet; 2014; 28(1-2):30-40. PubMed ID: 24506814
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lysosome dysfunction as a cause of neurodegenerative diseases: Lessons from frontotemporal dementia and amyotrophic lateral sclerosis.
    Root J; Merino P; Nuckols A; Johnson M; Kukar T
    Neurobiol Dis; 2021 Jul; 154():105360. PubMed ID: 33812000
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nuclear transport dysfunction: a common theme in amyotrophic lateral sclerosis and frontotemporal dementia.
    Jovičić A; Paul JW; Gitler AD
    J Neurochem; 2016 Aug; 138 Suppl 1():134-44. PubMed ID: 27087014
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The most prevalent genetic cause of ALS-FTD, C9orf72 synergizes the toxicity of ATXN2 intermediate polyglutamine repeats through the autophagy pathway.
    Ciura S; Sellier C; Campanari ML; Charlet-Berguerand N; Kabashi E
    Autophagy; 2016 Aug; 12(8):1406-8. PubMed ID: 27245636
    [TBL] [Abstract][Full Text] [Related]  

  • 7. UBQLN2/P62 cellular recycling pathways in amyotrophic lateral sclerosis and frontotemporal dementia.
    Fecto F; Siddique T
    Muscle Nerve; 2012 Feb; 45(2):157-62. PubMed ID: 22246868
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Analysis of known amyotrophic lateral sclerosis and frontotemporal dementia genes reveals a substantial genetic burden in patients manifesting both diseases not carrying the
    Dols-Icardo O; García-Redondo A; Rojas-García R; Borrego-Hernández D; Illán-Gala I; Muñoz-Blanco JL; Rábano A; Cervera-Carles L; Juárez-Rufián A; Spataro N; De Luna N; Galán L; Cortes-Vicente E; Fortea J; Blesa R; Grau-Rivera O; Lleó A; Esteban-Pérez J; Gelpi E; Clarimón J
    J Neurol Neurosurg Psychiatry; 2018 Feb; 89(2):162-168. PubMed ID: 28889094
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tale of two diseases: amyotrophic lateral sclerosis and frontotemporal dementia.
    Verma A
    Neurol India; 2014; 62(4):347-51. PubMed ID: 25237937
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Impaired protein degradation in FTLD and related disorders.
    Götzl JK; Lang CM; Haass C; Capell A
    Ageing Res Rev; 2016 Dec; 32():122-139. PubMed ID: 27166223
    [TBL] [Abstract][Full Text] [Related]  

  • 11. TBK1 mutation frequencies in French frontotemporal dementia and amyotrophic lateral sclerosis cohorts.
    Le Ber I; De Septenville A; Millecamps S; Camuzat A; Caroppo P; Couratier P; Blanc F; Lacomblez L; Sellal F; Fleury MC; Meininger V; Cazeneuve C; Clot F; Flabeau O; LeGuern E; Brice A;
    Neurobiol Aging; 2015 Nov; 36(11):3116.e5-3116.e8. PubMed ID: 26476236
    [TBL] [Abstract][Full Text] [Related]  

  • 12. ALS and FTD: Where RNA metabolism meets protein quality control.
    Mandrioli J; Mediani L; Alberti S; Carra S
    Semin Cell Dev Biol; 2020 Mar; 99():183-192. PubMed ID: 31254610
    [TBL] [Abstract][Full Text] [Related]  

  • 13. TDP-43 and FUS in amyotrophic lateral sclerosis and frontotemporal dementia.
    Mackenzie IR; Rademakers R; Neumann M
    Lancet Neurol; 2010 Oct; 9(10):995-1007. PubMed ID: 20864052
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Delineating the relationship between amyotrophic lateral sclerosis and frontotemporal dementia: Sequence and structure-based predictions.
    Kumar V; Islam A; Hassan MI; Ahmad F
    Biochim Biophys Acta; 2016 Sep; 1862(9):1742-54. PubMed ID: 27318084
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mutation analysis of the TIA1 gene in Chinese patients with amyotrophic lateral sclerosis and frontotemporal dementia.
    Yuan Z; Jiao B; Hou L; Xiao T; Liu X; Wang J; Xu J; Zhou L; Yan X; Tang B; Shen L
    Neurobiol Aging; 2018 Apr; 64():160.e9-160.e12. PubMed ID: 29370934
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Making connections: pathology and genetics link amyotrophic lateral sclerosis with frontotemporal lobe dementia.
    Fecto F; Siddique T
    J Mol Neurosci; 2011 Nov; 45(3):663-75. PubMed ID: 21901496
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evidence of a link between ubiquilin 2 and optineurin in amyotrophic lateral sclerosis.
    Osaka M; Ito D; Yagi T; Nihei Y; Suzuki N
    Hum Mol Genet; 2015 Mar; 24(6):1617-29. PubMed ID: 25398946
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pathogenesis of FUS-associated ALS and FTD: insights from rodent models.
    Nolan M; Talbot K; Ansorge O
    Acta Neuropathol Commun; 2016 Sep; 4(1):99. PubMed ID: 27600654
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lysosomal Dysfunction at the Centre of Parkinson's Disease and Frontotemporal Dementia/Amyotrophic Lateral Sclerosis.
    Wallings RL; Humble SW; Ward ME; Wade-Martins R
    Trends Neurosci; 2019 Dec; 42(12):899-912. PubMed ID: 31704179
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Association between TBK1 mutations and risk of amyotrophic lateral sclerosis/frontotemporal dementia spectrum: a meta-analysis.
    Cui R; Tuo M; Li P; Zhou C
    Neurol Sci; 2018 May; 39(5):811-820. PubMed ID: 29349657
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 36.